A Multicenter Randomized Non-Inferiority Study of Homoharringtonine Versus Etoposide in Induction Phase for Chinese Childhood Acute Myeloid Leukemia - a Report from China Children's Leukemia Group (CCLG)
第一作者单位:[1]Capital Med Univ, Beijing Childrens Hosp, Hematol Oncol Ctr, Natl Ctr Childrens Hlth, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Li Jing,Yu Jiaole,Zhang Ruidong,et al.A Multicenter Randomized Non-Inferiority Study of Homoharringtonine Versus Etoposide in Induction Phase for Chinese Childhood Acute Myeloid Leukemia - a Report from China Children's Leukemia Group (CCLG)[J].BLOOD.2019,134:doi:10.1182/blood-2019-127932.
APA:
Li, Jing,Yu, Jiaole,Zhang, Ruidong,Gao, Ju,Liang, Changda...&Zheng, Huyong.(2019).A Multicenter Randomized Non-Inferiority Study of Homoharringtonine Versus Etoposide in Induction Phase for Chinese Childhood Acute Myeloid Leukemia - a Report from China Children's Leukemia Group (CCLG).BLOOD,134,
MLA:
Li, Jing,et al."A Multicenter Randomized Non-Inferiority Study of Homoharringtonine Versus Etoposide in Induction Phase for Chinese Childhood Acute Myeloid Leukemia - a Report from China Children's Leukemia Group (CCLG)".BLOOD 134.(2019)